Development of a health communication campaign to promote the Texas prescription monitoring program

Mackert, Michael; Pounders, Kathrynn; Brown, Laura E.; Kirtz, Susan; Wagner, Jessica; Ring, David; Hill, Lucas G.; Wilcox, Gary B.; Murthy, Dhiraj; Tierney, William M.; Innerarity, Sheri; McGlone, Matthew S.; Steiker, Lori K. Holleran; DeSalvo, Karen B.; Bernhardt, Jay Michael; Pretorius, Kelly

doi:10.1080/07359683.2020.1802967

Cited by 3 publications

(8 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Study results are consistent with preliminary research findings from other state and local opioid misuse prevention campaigns [ 20 , 21 , 22 ]. The CDC has also launched a public education campaign called Rx Awareness to raise awareness of the opioid epidemic and lower prescription opioid misuse among young adults.…”

Section: Discussionsupporting

confidence: 90%

Educating Young Adults about Opioid Misuse: Evidence from a Mass Media Intervention

Rath

Perks

Vallone

et al. 2021

IJERPH

View full text Add to dashboard Cite

The US opioid epidemic is a serious public health problem. Rates of opioid misuse and dependence are highest for young adults ages 18–25. Prevention strategies that reduce prescription opioid misuse while decreasing stigma around dependence and treatment are critical components of addressing the epidemic. The Truth About Opioids, a mass media public education campaign, was designed to prevent opioid misuse and dependence among young adults. This study examined the intervention’s effectiveness to shift opioid-related knowledge, attitudes, and beliefs within targeted designated market areas (DMAs) over time. A sample of young adults (N = 1434) in DMAs with varying levels of media exposure was surveyed at baseline (June–September 2019) and post-intervention (July–August 2020). Logistic regression assessed associations between campaign awareness and campaign-targeted knowledge and attitudes, controlling for baseline variables. Those with any awareness had significantly higher odds of campaign-targeted opioid-related knowledge (versus no awareness) (low awareness OR = 1.52 (95% CI: 1.04, 2.24); high awareness OR = 2.47 (95% CI: 1.58, 3.87)). Those with campaign awareness were also more likely to report lower levels of opioid-related stigma and higher intentions to share information and talk to a friend about the epidemic. Mass media public education campaigns can help influence young adults’ opioid-related knowledge and attitudes.

show abstract

Section: Discussionsupporting

confidence: 90%

Educating Young Adults about Opioid Misuse: Evidence from a Mass Media Intervention

Rath

Perks

Vallone

et al. 2021

IJERPH

View full text Add to dashboard Cite

show abstract

“…The extracted data from the included studies were then classified into main conceptual categories and summarised to align with the scoping review objective and research questions. The data extraction results are presented in Tables S1 and S2 [18–166], Supporting Information.…”

Section: Resultsmentioning

confidence: 99%

“…Overall, half of the studies involved patients [9,18,22–24,26,27,32,34,36–38,41–43,45,46,48,50,53,54,59,62,63,65,66,71,73,75,77–80,84–86,88,90,93,95,97,98,100,101,104,105,108–110,115–118,121,123,125,130,131,134,140,144,146,147,149,151,152,154–156,158,159,161,163,165,167] and 47% included health‐care providers [11,19,20,25,29,30,33,35,37,39,40,43,44,49,51,54–61,67–69,71,72,74,76,80–83,87,91,93,94,96,102,103,106,111–114,119,120,122,124,125,127,128,130,132,133,136–139,141,143,145,147,148,150,153,157,160,162,165]. Some studies included both patient and provider populations [36, 37, 54, 59, 80, 93, 130, 147, 166].…”

Section: Resultsmentioning

confidence: 99%

“…Other studies examined diversion, prescription shopping and illicit drug use (23%), unintended consequences of PDMPs (15%) [5,18,19,32–34,36,39,41,42,47,48,53,62,73,75,78,95,99,105,123,131,138,164], and opioid dispensing (13%). Thirty‐nine implementation studies focused on attitudes and use of PDMPs (25%), followed by barriers (18%) and facilitators (14%) to use [11,20,30,37,39,40,49,58,60,65,68,72,74,76,82,87,90,91,93,94,96,100,102,107,113,122–125,128,135–137,139,143,146,159,162]. Fewer studies (7%) addressed PDMP systems and processes integration in the workplace [9,29,31,58,60,86,91,96,143,153,162] as shown in Figure 3.…”

Section: Resultsmentioning

confidence: 99%

“…The association between opioid-related outcomes and PDMP characteristics were explored in 38 studies (25% In terms of program quality, 15 studies (10%) reported on the lack of integration with other systems including electronic health records and hospital information exchange systems [11,21,31,47,49,55,58,65,72,94,96,121,122,128,137] and 11 studies (7%) discussed lack of ease of use. Barriers in the quality of PDMP information focused mainly on incomplete data related to lack of interstate sharing, security and privacy (10%), lack of timely data [11,55,66,86,94,102,107,125,143,162] and unreliable or inaccurate data, respectively (6%) [11,21,29,55,72,87,91,94,102,125] as shown (Figure 4).…”

Section: Research Themesmentioning

confidence: 99%

See 2 more Smart Citations

Mapping the research addressing prescription drug monitoring programs: A scoping review

Hoppe

Karimi

Khalil

2022

Drug and Alcohol Review

View full text Add to dashboard Cite

Issues. Prescription drug monitoring programs are a harm minimisation intervention and clinical decision support tool that address the public health concern surrounding prescription drug misuse. Given the large number of studies published to date and the ongoing implementation of these programs, it is important to map the literature and identify areas for further research to improve practice. Approach. A scoping review was undertaken to identify the research on prescription drug monitoring programs published between January 2015 and April 2021. Key Findings. A total of 153 citations were included in this scoping review. The majority of the studies originated from the USA and were quantitative. Results on program effectiveness are mixed and mainly examine their association with opioid-related outcomes. Unintended consequences are revealed in the literature and this review also highlights barriers to program use. Implications. Overall, findings are mixed despite the large number of studies published to date. Mapping the literature identifies priority areas for further research that can advise policymakers and clinicians on practice improvement. Conclusion. Results on prescription drug monitoring program effectiveness are mixed and mainly examine their association with opioid-related outcomes. This review highlights barriers to prescription drug monitoring program effectiveness related to program use and system integration. Further research is needed in these areas to improve prescription drug monitoring program use and patient outcomes.

show abstract

Evidence-Based Health Communication in Practice: Driving Funding, Research, and Training Through the University of Texas at Austin Center for Health Communication

Mackert,

Shi,

De Luca

et al. 2024

Health Communication

View full text Add to dashboard Cite

Development of a health communication campaign to promote the Texas prescription monitoring program

Cited by 3 publications

References 7 publications

Educating Young Adults about Opioid Misuse: Evidence from a Mass Media Intervention

Educating Young Adults about Opioid Misuse: Evidence from a Mass Media Intervention

Mapping the research addressing prescription drug monitoring programs: A scoping review

Evidence-Based Health Communication in Practice: Driving Funding, Research, and Training Through the University of Texas at Austin Center for Health Communication

Contact Info

Product

Resources

About